摘要
目的:比较肾性骨病方对不同阶段5/6肾切除小鼠骨丢失的保护作用机制。方法:3个月龄C57BL/6J小鼠150只,建立慢性肾衰小鼠模型,术后随机分为假手术组、模型组、罗盖全组、肾性骨病方组,分别在术后1周和4周时给予肾性骨病方以及罗盖全灌胃。各组给药8周后,取小鼠L5椎体、血清和肾脏组织,分别检测血清肌酐(CREA)、尿素氮(BUN),以评估肾脏功能;L5椎体进行阿尔辛兰/橙黄G染色、Micro-CT扫描加重建、免疫组化检测评估骨质情况。结果:和假手术组相比,模型组小鼠血清肌酐、血清尿素氮明显升高;和模型组相比,早期应用肾性骨病方干预后小鼠腰椎骨丢失情况较晚期各组得到明显改善;早期组小鼠L5腰椎Osterix表达明显升高而Cathepsin K表达明显降低;与之一致,TRAP染色显示早期应用肾性骨病方可以显著抑制破骨细胞活性,降低破骨细胞数量。结论:早期应用肾性骨病方可以有效改善5/6肾切除小鼠肾功能,缓解骨丢失。
Objective:To compare the protective mechanism of shenxinggubing decoction on bone loss in 5/6 nephrectomized mice at different stages. Methods:A total of 150 male C57 BL/6 J mice of 3-month-old were selected to establish the mouse model of chronic renal failure and randomly divided into sham group, model group, Shenxinggubing(SXGBF) group and Rocaltrol group. Shenxinggubing decoction and Rocaltrol were orally administrated at postoperative 1 week stage and 4 weeks stage respectively. After 8 weeks administration, L5 vertebrae, serum and kidney tissue of mice were taken to detect serum creatinine(CREA) and blood urea nitrogen(BUN). Arsine blue/orange G, Micro-CT scanning and reconstruction, and immunohistochemistry was used to evaluate bone condition in lumbar 5 vertebrae(L5). Results:Compared with sham group, serum CREA and BUN were significantly increased in model group. Compared with the model group, the bone loss of mics lumbar vertebra in the groups with early intervention of SXGBF decoction were significant improved than the late groups. In the early group, the expression of osterix in L5 lumbar vertebra was significantly increased and Cathepsin K was significantly decreased. In accordance with this, TRAP staining showed that early application of kidney osteopathy prescription could significantly inhibit the activity of osteoclasts and reduce the number of osteoclasts. Conclusion:The early application of SXGBF decoction effectively relieve renal insufficiency and bone loss in 5/6 nephrectomized mice.
作者
张浩
王晶
周琳
赵东峰
赵永见
卫晓恩
王拥军
舒冰
ZHANG Hao;WANG Jing;ZHOU Lin;ZHAO Dongfeng;ZHAO Yongjian;WEI Xiaoen;WANG Yongjun;SHU Bing(Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200000,China;Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Institute of Spinal Diseases,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Key Laboratory of Ministry of Education(Theory and Therapy of Muscles and Bones),Shanghai 200032,China;Shanghai Geriatric Institute of Chinese Medicine,Shanghai 200000,China)
出处
《中国中医骨伤科杂志》
CAS
2021年第10期1-8,共8页
Chinese Journal of Traditional Medical Traumatology & Orthopedics
基金
国家重点研发计划项目(2018YFC1704300)
国家自然科学基金项目(81673991,81973876)
上海市重中之重临床医学中心建设项目(2017ZZ01010)
上海市卫计委科研项目(20174Y0192)
教育部创新团队发展计划项目(IRT1270)
科技部重点领域创新团队项目(2015)。
关键词
肾性骨病
5/6肾切除
肾性骨病方
肾功能
骨丢失
renal osteodystrophy
Shenxinggubing decoction
5/6 nephrectomy
renal function
bone loss